biosimilar pipeline drugs - related partnerships

1. PARTNERSHIPS
BIOSIMILARS
---Around 100 companies
--- Around 63 deals
--- FDA Approved biologicals
--- EU approved biosimilars
--- Biosimilars-Clinical trials

2. Partnerships in Biosimilars
35
30
25
20
15 29
Deals
10
15
5
6 7
2 2 2 1
0
2005 2006 2007 2008 2009 2010 2011 2012

3.  Company
 BioPartners GmbH
 Partner
 The Medical House

 Date
 2/22/2005
 Type
 License, Supply Agreement
 Deal Value
 -
 Title
 BioPartners GmbH Signs 10 Year License and Supply Agreement With The Medical House for Needle-Free
Delivery System for Human Growth Hormone
 Summary
 BioPartners and The Medical House PLC are pleased to announce a 10 year agreement for license and supply
of TMH's GH1 reusable, spring-powered, needle-free delivery system for the delivery of BioPartners'
recombinant human growth hormone product, Valtropin(tm) (somatropin). The agreement is on an exclusive
world-wide basis and follows from the development agreement between the companies which was signed in
June 2002. The GH1 received CE mark regulatory approval in 2003.
 Product
 Valtropin

4. THANK YOU
 Please contact at sahiinfotech9@gmail.com